CREATIVE BIOMOLECULES INC
10-C, 1996-07-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: FRANKLIN VALUE INVESTORS TRUST, 497, 1996-07-11
Next: VITAFORT INTERNATIONAL CORP, S-8, 1996-07-11



<PAGE>   1
Form 10-C

Securities and Exchange Commission
Washington, DC 20549

Report by issuer of securities quoted on The Nasdaq Stock Market[Service mark],
filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
and Rule 13a-17 or 15d-17 thereunder.

EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER: Creative BioMolecules, Inc.
                                             -----------------------------------

ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 45 South Street, Hopkinton,
                                       -----------------------------------------
                                        Massachusetts 01748
                                       -----------------------------------------

ISSUER'S TELEPHONE NUMBER (INCLUDING AREA CODE): (508) 435-9001
                                                --------------------------------

I. Change in Number of Shares Outstanding
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:

1. Title of security  Common Stock, $.01 par value per share
                     -----------------------------------------------------------

2. Number of shares outstanding before the change  29,072,730
                                                  ------------------------------

3. Number of shares outstanding after the change   31,072,730
                                                 -------------------------------

4. Effective date of change  July 2, 1996
                            ----------------------------------------------------

5. Method of change  Public Offering
                    ------------------------------------------------------------

Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
                                                              ------------------

- --------------------------------------------------------------------------------

Give brief description of transaction  Public Offering of 2,000,000 shares of
                                      ------------------------------------------
Common Stock (excluding 300,000 shares subject to an over-allotment option
- ------------
granted to the Underwriters)


II. Change in Name of Issuer

1. Name prior to change
                        --------------------------------------------------------

2. Name after change
                     -----------------------------------------------------------

3. Effective date of charter amendment changing name
                                                     ---------------------------

4. Date of shareholder approval of change, if required
                                                       -------------------------

7/11/96      /s/ Wayne E. Mayhew III, VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
- --------------------------------------------------------------------------------
DATE                 OFFICER'S SIGNATURE AND TITLE





[Copyright]June 1994, The Nasdaq Stock Market, Inc. All rights reserved. Nasdaq
is a registered service mark of The Nasdaq Stock Market, Inc. The Nasdaq Stock 
Market is a service mark of The Nasdaq Stock Market, Inc. 







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission